Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2005-11-16 15:48:42 UTC |
---|
Update Date | 2022-09-22 18:34:12 UTC |
---|
HMDB ID | HMDB0000212 |
---|
Secondary Accession Numbers | - HMDB0000835
- HMDB00212
- HMDB00835
|
---|
Metabolite Identification |
---|
Common Name | N-Acetylgalactosamine |
---|
Description | N-Acetylgalactosamine, also known as GalNAc, belongs to the class of organic compounds known as N-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moiety in which the oxygen atom is replaced by an N-acyl group. N-Acetylgalactosamine is also classified as an amino sugar derivative of galactose. In humans GalNAc functions as the terminal carbohydrate forming the antigen of blood group A. GalNAc is typically the first monosaccharide that connects serine or threonine during protein O-glycosylation and the formation of glycoproteins. This is often referred to as mucin-type O-glycosylation, as the mucins (a class of a family of high molecular weight, heavily glycosylated proteins produced by epithelial tissues in most animals which have an ability to form gels) are heavily O-GalNAc modified. Interestingly, mammals have genes encoding for approximately 20 different polypeptide-N-acetylgalactosaminyltransferases (ppGalNAcTs), all of which transfer GalNAc from UDP-GalNAc to a hydroxyl-containing amino acids such as serine or threonine. N- O-GalNAc-containing glycoproteins appear to play a variety of essential roles. Among these is the ability of the mucins to hydrate and protect tissues by trapping bacteria. These O-glycans can also significantly alter the conformation of the protein and on the heavily modified proteins may protect the polypeptide from proteolytic digestion. O-GalNAc structures also appear to play an essential role in sperm-egg interactions. From a pathophysiological perspective, O-GalNAc modification appears to play a critical role in the immune system, cell-cell interactions, and cancer. N-Acetylgalactosamine is an important constituent of brain heteropolysaccharides (glycoproteins). The concentration of the N-acetylgalactosamine-containing glycoproteins in the 3-year-old cerebral gray matter from human brain is 7-15 times greater than in 8-year old tissue and 15-30 times greater than in 72-year-old tissue. Outside of the human body, N-Acetylgalactosamine has been detected, but not quantified in, several different foods, such as prickly pears, italian sweet red peppers, wheats, silver lindens, and sour cherries. This could make N-acetylgalactosamine a potential biomarker for the consumption of these foods. |
---|
Structure | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8+/m1/s1 |
---|
Synonyms | Value | Source |
---|
2-(Acetylamino)-2-deoxy-alpha-D-galactopyranose | ChEBI | alpha-GalNAc | ChEBI | alpha-GalpNAc | ChEBI | GalNAc-alpha | ChEBI | Tn | ChEBI | TN Antigen saccharide | ChEBI | TN Antigen saccharide component | ChEBI | TN Saccharide | ChEBI | TN Saccharide component | ChEBI | 2-(Acetylamino)-2-deoxy-a-D-galactopyranose | Generator | 2-(Acetylamino)-2-deoxy-α-D-galactopyranose | Generator | a-GalNAc | Generator | Α-galnac | Generator | a-GalpNAc | Generator | Α-galpnac | Generator | GalNAc-a | Generator | GalNAc-α | Generator | 2-Acetamido-2-deoxy-a-D-allopyranose | HMDB | 2-Acetamido-2-deoxy-a-D-glucopyranose | HMDB | 2-Acetamido-2-deoxy-alpha-D-allopyranose | HMDB | 2-Acetamido-2-deoxy-alpha-D-glucopyranose | HMDB | 2-Acetamido-2-deoxy-alpha-delta-allopyranose | HMDB | 2-Acetamido-2-deoxy-alpha-delta-glucopyranose | HMDB | 2-Acetamido-2-deoxy-b-D-glucopyranose | HMDB | 2-Acetamido-2-deoxy-beta-D-glucopyranose | HMDB | 2-Acetamido-2-deoxy-beta-delta-glucopyranose | HMDB | 2-Acetamido-2-desoxy-b-D-talofuranose | HMDB | 2-Acetamido-2-desoxy-beta-D-talofuranose | HMDB | 2-Acetamido-2-desoxy-beta-delta-talofuranose | HMDB | 2-Acetamino-2-deoxy-a-D-glucose | HMDB | 2-Acetamino-2-deoxy-alpha-D-glucose | HMDB | 2-Acetamino-2-deoxy-alpha-delta-glucose | HMDB | 2-Acetamino-2-desoxy-a-D-glucopyranose | HMDB | 2-Acetamino-2-desoxy-alpha-D-glucopyranose | HMDB | 2-Acetamino-2-desoxy-alpha-delta-glucopyranose | HMDB | 2-Acetamino-2-desoxy-D-galaktose | HMDB | 2-Acetamino-2-desoxy-D-glucose | HMDB | 2-Acetamino-2-desoxy-delta-galaktose | HMDB | 2-Acetamino-2-desoxy-delta-glucose | HMDB | 2-Acetylamino-2-deoxy-a-D-galactopyranose | HMDB | 2-Acetylamino-2-deoxy-a-D-glucopyranose | HMDB | 2-Acetylamino-2-deoxy-a-D-mannopyranose | HMDB | 2-Acetylamino-2-deoxy-alpha-D-galactopyranose | HMDB | 2-Acetylamino-2-deoxy-alpha-D-glucopyranose | HMDB | 2-Acetylamino-2-deoxy-alpha-D-mannopyranose | HMDB | 2-Acetylamino-2-deoxy-alpha-delta-galactopyranose | HMDB | 2-Acetylamino-2-deoxy-alpha-delta-glucopyranose | HMDB | 2-Acetylamino-2-deoxy-alpha-delta-mannopyranose | HMDB | 2-Acetylamino-2-deoxy-b-D-allopyranose | HMDB | 2-Acetylamino-2-deoxy-b-D-altropyranose | HMDB | 2-Acetylamino-2-deoxy-b-D-galactopyranose | HMDB | 2-Acetylamino-2-deoxy-b-D-glucopyranose | HMDB | 2-Acetylamino-2-deoxy-b-D-mannopyranose | HMDB | 2-Acetylamino-2-deoxy-beta-D-allopyranose | HMDB | 2-Acetylamino-2-deoxy-beta-D-altropyranose | HMDB | 2-Acetylamino-2-deoxy-beta-D-galactopyranose | HMDB | 2-Acetylamino-2-deoxy-beta-D-glucopyranose | HMDB | 2-Acetylamino-2-deoxy-beta-D-mannopyranose | HMDB | 2-Acetylamino-2-deoxy-beta-delta-allopyranose | HMDB | 2-Acetylamino-2-deoxy-beta-delta-altropyranose | HMDB | 2-Acetylamino-2-deoxy-beta-delta-galactopyranose | HMDB | 2-Acetylamino-2-deoxy-beta-delta-glucopyranose | HMDB | 2-Acetylamino-2-deoxy-beta-delta-mannopyranose | HMDB | 2-Acetylamino-2-desoxy-a-D-galaktose | HMDB | 2-Acetylamino-2-desoxy-a-D-mannose | HMDB | 2-Acetylamino-2-desoxy-alpha-D-galaktose | HMDB | 2-Acetylamino-2-desoxy-alpha-D-mannose | HMDB | 2-Acetylamino-2-desoxy-alpha-delta-galaktose | HMDB | 2-Acetylamino-2-desoxy-alpha-delta-mannose | HMDB | 2-Acetylamino-2-desoxy-b-D-galaktose | HMDB | 2-Acetylamino-2-desoxy-b-D-mannose | HMDB | 2-Acetylamino-2-desoxy-beta-D-galaktose | HMDB | 2-Acetylamino-2-desoxy-beta-D-mannose | HMDB | 2-Acetylamino-2-desoxy-beta-delta-galaktose | HMDB | 2-Acetylamino-2-desoxy-beta-delta-mannose | HMDB | 2-Acetylamino-2-desoxy-D-mannose | HMDB | 2-Acetylamino-2-desoxy-delta-mannose | HMDB | 2-Acetylamino-2-desoxy-DL-glucopyranose | HMDB | 2-Acetylamino-a-D-2-deoxy-galactopyranose | HMDB | 2-Acetylamino-a-D-2-deoxy-glucopyranose | HMDB | 2-Acetylamino-a-D-2-deoxy-glucose | HMDB | 2-Acetylamino-a-D-2-deoxy-mannopyranose | HMDB | 2-Acetylamino-alpha-D-2-deoxy-galactopyranose | HMDB | 2-Acetylamino-alpha-D-2-deoxy-glucopyranose | HMDB | 2-Acetylamino-alpha-D-2-deoxy-glucose | HMDB | 2-Acetylamino-alpha-D-2-deoxy-mannopyranose | HMDB | 2-Acetylamino-alpha-delta-2-deoxy-galactopyranose | HMDB | 2-Acetylamino-alpha-delta-2-deoxy-glucopyranose | HMDB | 2-Acetylamino-alpha-delta-2-deoxy-glucose | HMDB | 2-Acetylamino-alpha-delta-2-deoxy-mannopyranose | HMDB | 2-Acetylamino-b-D-2-deoxy-galactopyranose | HMDB | 2-Acetylamino-b-D-2-deoxy-glucopyranose | HMDB | 2-Acetylamino-b-D-2-deoxy-mannopyranose | HMDB | 2-Acetylamino-beta-D-2-deoxy-galactopyranose | HMDB | 2-Acetylamino-beta-D-2-deoxy-glucopyranose | HMDB | 2-Acetylamino-beta-D-2-deoxy-mannopyranose | HMDB | 2-Acetylamino-beta-delta-2-deoxy-galactopyranose | HMDB | 2-Acetylamino-beta-delta-2-deoxy-glucopyranose | HMDB | 2-Acetylamino-beta-delta-2-deoxy-mannopyranose | HMDB | 2-Acetylamino-D-2-deoxy-galactose | HMDB | 2-Acetylamino-D-2-deoxy-glucose | HMDB | 2-Acetylamino-D-2-deoxy-gulose | HMDB | 2-Acetylamino-D-2-deoxy-idose | HMDB | 2-Acetylamino-D-2-deoxy-mannose | HMDB | 2-Acetylamino-D-2-deoxy-talose | HMDB | 2-Acetylamino-delta-2-deoxy-galactose | HMDB | 2-Acetylamino-delta-2-deoxy-glucose | HMDB | 2-Acetylamino-delta-2-deoxy-gulose | HMDB | 2-Acetylamino-delta-2-deoxy-idose | HMDB | 2-Acetylamino-delta-2-deoxy-mannose | HMDB | 2-Acetylamino-delta-2-deoxy-talose | HMDB | 2-Acetylamino-L-2-deoxy-galactose | HMDB | 2-Acetylamino-L-2-deoxy-mannose | HMDB | a-2-Acetamido-2-deoxy-D-galactose | HMDB | alpha-2-Acetamido-2-deoxy-D-galactose | HMDB | alpha-2-Acetamido-2-deoxy-delta-galactose | HMDB | GalNAc | HMDB | N-(2,4,5-Trihydroxy-6-hydroxymethyl-tetrahydro-pyran-3-yl)-acetamide | HMDB | N-Acetyl-a-D-glucosamine | HMDB | N-Acetyl-alpha-D-glucosamine | HMDB | N-Acetyl-alpha-delta-glucosamine | HMDB | N-Acetyl-D-allosamine | HMDB | N-Acetyl-D-galactosamine | HMDB | N-Acetyl-delta-allosamine | HMDB | N-Acetyl-delta-galactosamine | HMDB | N-Acetylgalactosamin | HMDB | N-Acetylglucosamin | HMDB | N-Acetylgluosamin | HMDB | N-Acetylmannosamin | HMDB | 2 Acetamido 2 deoxy D galactose | HMDB | 2-Acetamido-2-D-galactopyranose | HMDB | Acetylgalactosamine | HMDB | 2-Acetamido-2-deoxygalactose | HMDB | N Acetyl D galactosamine | HMDB | 2 Acetamido 2 D galactopyranose | HMDB | 2 Acetamido 2 deoxygalactose | HMDB | 2-Acetamido-2-deoxy-D-galactose | HMDB | N-Acetyl-a-D-galactosamine | HMDB | N-Acetyl-α-D-galactosamine | HMDB | a-N-Acetyl-D-galactosamine | HMDB | Α-N-acetyl-D-galactosamine | HMDB |
|
---|
Chemical Formula | C8H15NO6 |
---|
Average Molecular Weight | 221.2078 |
---|
Monoisotopic Molecular Weight | 221.089937217 |
---|
IUPAC Name | N-[(2S,3R,4R,5R,6R)-2,4,5-trihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide |
---|
Traditional Name | α-GalNAc |
---|
CAS Registry Number | 1811-31-0 |
---|
SMILES | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O |
---|
InChI Identifier | InChI=1S/C8H15NO6/c1-3(11)9-5-7(13)6(12)4(2-10)15-8(5)14/h4-8,10,12-14H,2H2,1H3,(H,9,11)/t4-,5-,6+,7-,8+/m1/s1 |
---|
InChI Key | OVRNDRQMDRJTHS-CBQIKETKSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as n-acyl-alpha-hexosamines. These are carbohydrate derivatives containing a hexose moiety in which the oxygen atom is replaced by an n-acyl group. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic oxygen compounds |
---|
Class | Organooxygen compounds |
---|
Sub Class | Carbohydrates and carbohydrate conjugates |
---|
Direct Parent | N-acyl-alpha-hexosamines |
---|
Alternative Parents | |
---|
Substituents | - N-acyl-alpha-hexosamine
- Hexose monosaccharide
- Monosaccharide
- Oxane
- Hemiacetal
- Secondary alcohol
- Carboximidic acid
- Carboximidic acid derivative
- Oxacycle
- Organoheterocyclic compound
- Polyol
- Organic 1,3-dipolar compound
- Propargyl-type 1,3-dipolar organic compound
- Alcohol
- Organonitrogen compound
- Organic nitrogen compound
- Primary alcohol
- Organopnictogen compound
- Hydrocarbon derivative
- Aliphatic heteromonocyclic compound
|
---|
Molecular Framework | Aliphatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Not Available | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 172 - 173 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
N-Acetylgalactosamine,1TMS,isomer #1 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO)[C@H](O)[C@@H]1O | 1894.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,1TMS,isomer #2 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C)[C@H](O)[C@@H]1O | 1900.1 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,1TMS,isomer #3 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O[Si](C)(C)C)[C@@H]1O | 1898.0 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,1TMS,isomer #4 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O[Si](C)(C)C | 1908.2 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,1TMS,isomer #5 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O)[Si](C)(C)C | 1835.0 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #1 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O)[C@@H]1O | 1915.8 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #10 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 1897.1 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #2 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO)[C@H](O[Si](C)(C)C)[C@@H]1O | 1930.3 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #3 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO)[C@H](O)[C@@H]1O[Si](C)(C)C | 1938.6 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #4 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO)[C@H](O)[C@@H]1O)[Si](C)(C)C | 1890.6 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #5 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O | 1939.6 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #6 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C)[C@H](O)[C@@H]1O[Si](C)(C)C | 1939.6 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #7 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C)[C@H](O)[C@@H]1O)[Si](C)(C)C | 1911.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #8 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 1933.2 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TMS,isomer #9 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO)[C@H](O[Si](C)(C)C)[C@@H]1O)[Si](C)(C)C | 1895.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #1 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O | 2003.5 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #10 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 1967.8 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #2 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O)[C@@H]1O[Si](C)(C)C | 2011.5 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #3 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O)[C@@H]1O)[Si](C)(C)C | 1939.5 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #4 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2016.7 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #5 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO)[C@H](O[Si](C)(C)C)[C@@H]1O)[Si](C)(C)C | 1961.8 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #6 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO)[C@H](O)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 1981.0 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #7 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2006.4 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #8 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O)[Si](C)(C)C | 1967.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TMS,isomer #9 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C)[C@H](O)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 1970.5 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TMS,isomer #1 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C | 2036.2 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TMS,isomer #2 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O)[Si](C)(C)C | 2024.8 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TMS,isomer #3 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 2040.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TMS,isomer #4 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 2039.6 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TMS,isomer #5 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 2031.3 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,5TMS,isomer #1 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 2092.3 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,5TMS,isomer #1 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 2154.1 | Standard non polar | 33892256 | N-Acetylgalactosamine,5TMS,isomer #1 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C)O[C@H](CO[Si](C)(C)C)[C@H](O[Si](C)(C)C)[C@@H]1O[Si](C)(C)C)[Si](C)(C)C | 2100.6 | Standard polar | 33892256 | N-Acetylgalactosamine,1TBDMS,isomer #1 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO)[C@H](O)[C@@H]1O | 2151.2 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,1TBDMS,isomer #2 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H]1O | 2148.3 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,1TBDMS,isomer #3 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 2164.7 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,1TBDMS,isomer #4 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2166.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,1TBDMS,isomer #5 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O)[Si](C)(C)C(C)(C)C | 2109.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #1 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H]1O | 2423.5 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #10 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2384.2 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #2 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 2439.8 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #3 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2433.2 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #4 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO)[C@H](O)[C@@H]1O)[Si](C)(C)C(C)(C)C | 2371.0 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #5 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 2427.0 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #6 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2436.0 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #7 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H]1O)[Si](C)(C)C(C)(C)C | 2406.0 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #8 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 2423.5 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,2TBDMS,isomer #9 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O)[Si](C)(C)C(C)(C)C | 2389.3 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #1 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O | 2686.1 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #10 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2624.3 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #2 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C | 2664.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #3 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H]1O)[Si](C)(C)C(C)(C)C | 2622.2 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #4 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 2659.1 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #5 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O)[Si](C)(C)C(C)(C)C | 2629.1 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #6 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2628.6 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #7 | CC(=O)N[C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 2682.8 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #8 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O)[Si](C)(C)C(C)(C)C | 2658.8 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,3TBDMS,isomer #9 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2650.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TBDMS,isomer #1 | CC(=O)N[C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C | 2872.7 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TBDMS,isomer #2 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O)[Si](C)(C)C(C)(C)C | 2860.6 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TBDMS,isomer #3 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2859.4 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TBDMS,isomer #4 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2849.9 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,4TBDMS,isomer #5 | CC(=O)N([C@H]1[C@@H](O)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2868.3 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,5TBDMS,isomer #1 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3101.4 | Semi standard non polar | 33892256 | N-Acetylgalactosamine,5TBDMS,isomer #1 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 3050.3 | Standard non polar | 33892256 | N-Acetylgalactosamine,5TBDMS,isomer #1 | CC(=O)N([C@H]1[C@@H](O[Si](C)(C)C(C)(C)C)O[C@H](CO[Si](C)(C)C(C)(C)C)[C@H](O[Si](C)(C)C(C)(C)C)[C@@H]1O[Si](C)(C)C(C)(C)C)[Si](C)(C)C(C)(C)C | 2705.7 | Standard polar | 33892256 |
|
---|
Spectra |
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-0kn9-9510000000-8257171f06e4c704d6c7 | 2017-08-28 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (4 TMS) - 70eV, Positive | splash10-006y-5125900000-2d5a04f77a0106be2e7f | 2017-10-06 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_1_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_1_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_1_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_1_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_1_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_6) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_7) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_8) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_9) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_2_10) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_3_1) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_3_2) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_3_3) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_3_4) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_3_5) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_3_6) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - N-Acetylgalactosamine GC-MS (TMS_3_7) - 70eV, Positive | Not Available | 2021-11-05 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine Quattro_QQQ 10V, Positive-QTOF (Annotated) | splash10-0udr-0970000000-f6d052d0a798e4e2edee | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine Quattro_QQQ 25V, Positive-QTOF (Annotated) | splash10-003s-9500000000-8dc5f0ece3a66ea3928d | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine Quattro_QQQ 40V, Positive-QTOF (Annotated) | splash10-001j-9000000000-23b0bbbd1c8a5ad5551e | 2012-07-24 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 20V, Negative-QTOF | splash10-0a4i-9300000000-c5b00d3c0c640460939c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 35V, Negative-QTOF | splash10-0kmi-7690000000-0379d0dd56fec2bed44f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 10V, Negative-QTOF | splash10-0a4i-9510000000-422cde531f065d5e4946 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 40V, Negative-QTOF | splash10-0540-9100000000-0ce448f2f58df56a856d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 20V, Positive-QTOF | splash10-002n-9800000000-ec7209a768c753d47709 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 10V, Positive-QTOF | splash10-000i-2900000000-b13dd76a5e0c01867c4c | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 35V, Positive-QTOF | splash10-002u-2900000000-166169863c3bda7fcd02 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 35V, Positive-QTOF | splash10-004u-2900000000-dac77e9deddac603f878 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 10V, Positive-QTOF | splash10-002u-2910000000-f4490188227492913aee | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 40V, Positive-QTOF | splash10-0f8a-9000000000-95e011521a10f2c0f12a | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 20V, Positive-QTOF | splash10-003e-9700000000-8e49c95be0c9d841080f | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - N-Acetylgalactosamine 40V, Positive-QTOF | splash10-00lv-9000000000-2cc319b93d5874dd2978 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 10V, Positive-QTOF | splash10-00fr-0690000000-76eea9cfdbd489aa104e | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 20V, Positive-QTOF | splash10-0imi-2930000000-440841c73a9eca07c5df | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 40V, Positive-QTOF | splash10-02nm-9600000000-e4f081a779068ec3341c | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 10V, Negative-QTOF | splash10-00dr-8920000000-b0218f0ec55de02b404d | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 20V, Negative-QTOF | splash10-0pb9-9820000000-ecdc02d885b289c2e845 | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 40V, Negative-QTOF | splash10-0a4i-9100000000-582cce650e2eb7e1c0ea | 2017-07-26 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 10V, Positive-QTOF | splash10-0udi-0390000000-3820a7eec5a8c72f49d9 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 20V, Positive-QTOF | splash10-0h90-9740000000-db880363194a3979c637 | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 40V, Positive-QTOF | splash10-0229-9200000000-cdcf015aa799dc7d6d8b | 2021-09-24 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - N-Acetylgalactosamine 10V, Negative-QTOF | splash10-0a4i-9500000000-2c2b09cb6bfb29039085 | 2021-09-24 | Wishart Lab | View Spectrum |
NMR SpectraSpectrum Type | Description | Deposition Date | Source | View |
---|
Experimental 1D NMR | 1H NMR Spectrum (1D, 500 MHz, H2O, experimental) | 2012-12-04 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 13C NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Predicted 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | 2021-09-16 | Wishart Lab | View Spectrum | Experimental 2D NMR | [1H, 13C]-HSQC NMR Spectrum (2D, 600 MHz, H2O, experimental) | 2012-12-05 | Wishart Lab | View Spectrum |
|
---|
Biological Properties |
---|
Cellular Locations | |
---|
Biospecimen Locations | |
---|
Tissue Locations | - Adipose Tissue
- Brain
- Epidermis
- Intestine
- Liver
- Neuron
- Pancreas
- Placenta
- Prostate
- Skeletal Muscle
- Spleen
- Testis
|
---|
Pathways | |
---|
Normal Concentrations |
---|
| |
Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details | Saliva | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Male | Normal | | details |
|
---|
Abnormal Concentrations |
---|
| |
Blood | Expected but not Quantified | Not Quantified | Not Specified | Not Specified | Cancer patients undergoing total body irradiation | | details | Feces | Detected but not Quantified | Not Quantified | Adult (>18 years old) | Both | Colorectal Cancer | | details | Urine | Detected but not Quantified | Not Quantified | Not Specified | Not Specified | Cancer patients undergoing total body irradiation | | details |
|
---|
Associated Disorders and Diseases |
---|
Disease References | Colorectal cancer |
---|
- Brown DG, Rao S, Weir TL, O'Malia J, Bazan M, Brown RJ, Ryan EP: Metabolomics and metabolic pathway networks from human colorectal cancers, adjacent mucosa, and stool. Cancer Metab. 2016 Jun 6;4:11. doi: 10.1186/s40170-016-0151-y. eCollection 2016. [PubMed:27275383 ]
|
|
---|
Associated OMIM IDs | |
---|
External Links |
---|
DrugBank ID | DB03567 |
---|
Phenol Explorer Compound ID | Not Available |
---|
FooDB ID | FDB031022 |
---|
KNApSAcK ID | Not Available |
---|
Chemspider ID | 76020 |
---|
KEGG Compound ID | C01074 |
---|
BioCyc ID | CPD-3604 |
---|
BiGG ID | 36880 |
---|
Wikipedia Link | N-Acetylgalactosamine |
---|
METLIN ID | 5222 |
---|
PubChem Compound | 84265 |
---|
PDB ID | Not Available |
---|
ChEBI ID | 40356 |
---|
Food Biomarker Ontology | Not Available |
---|
VMH ID | ACGAL |
---|
MarkerDB ID | Not Available |
---|
Good Scents ID | Not Available |
---|
References |
---|
Synthesis Reference | Cardini, C. E.; Leloir, Luis F. Enzymic formation of acetylgalactosamine. Journal of Biological Chemistry (1957), 225 317-24. |
---|
Material Safety Data Sheet (MSDS) | Download (PDF) |
---|
General References | - Mazany KD, Peng T, Watson CE, Tabas I, Williams KJ: Human chondroitin 6-sulfotransferase: cloning, gene structure, and chromosomal localization. Biochim Biophys Acta. 1998 Jul 1;1407(1):92-7. [PubMed:9639683 ]
- Zhang Y, Iwasaki H, Wang H, Kudo T, Kalka TB, Hennet T, Kubota T, Cheng L, Inaba N, Gotoh M, Togayachi A, Guo J, Hisatomi H, Nakajima K, Nishihara S, Nakamura M, Marth JD, Narimatsu H: Cloning and characterization of a new human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase, designated pp-GalNAc-T13, that is specifically expressed in neurons and synthesizes GalNAc alpha-serine/threonine antigen. J Biol Chem. 2003 Jan 3;278(1):573-84. Epub 2002 Oct 28. [PubMed:12407114 ]
- White T, Bennett EP, Takio K, Sorensen T, Bonding N, Clausen H: Purification and cDNA cloning of a human UDP-N-acetyl-alpha-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase. J Biol Chem. 1995 Oct 13;270(41):24156-65. [PubMed:7592619 ]
- Sreekumar A, Poisson LM, Rajendiran TM, Khan AP, Cao Q, Yu J, Laxman B, Mehra R, Lonigro RJ, Li Y, Nyati MK, Ahsan A, Kalyana-Sundaram S, Han B, Cao X, Byun J, Omenn GS, Ghosh D, Pennathur S, Alexander DC, Berger A, Shuster JR, Wei JT, Varambally S, Beecher C, Chinnaiyan AM: Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature. 2009 Feb 12;457(7231):910-4. doi: 10.1038/nature07762. [PubMed:19212411 ]
- Nakagawa F, Schulte BA, Spicer SS: Lectin cytochemical evaluation of somatosensory neurons and their peripheral and central processes in rat and man. Cell Tissue Res. 1986;245(3):579-89. [PubMed:3757018 ]
- Kamakura K, Kaida K, Kusunoki S, Miyamoto N, Masaki T, Nakamura R, Motoyoshi K, Fukuda J: Harmful effects of anti-GalNAc-GD1a antibodies and TNF-alpha on rat dorsal root ganglia. J Peripher Nerv Syst. 2005 Jun;10(2):190-201. [PubMed:15958130 ]
- Petri WA Jr, Chaudhry O, Haque R, Houpt E: Adherence-blocking vaccine for amebiasis. Arch Med Res. 2006 Feb;37(2):288-91. [PubMed:16380334 ]
- Petry K, Greinix HT, Nudelman E, Eisen H, Hakomori S, Levy HL, Reichardt JK: Characterization of a novel biochemical abnormality in galactosemia: deficiency of glycolipids containing galactose or N-acetylgalactosamine and accumulation of precursors in brain and lymphocytes. Biochem Med Metab Biol. 1991 Aug;46(1):93-104. [PubMed:1931160 ]
- Kaida K, Kusunoki S, Kamakura K, Motoyoshi K, Kanazawa I: GalNAc-GD1a in human peripheral nerve: target sites of anti-ganglioside antibody. Neurology. 2003 Aug 26;61(4):465-70. [PubMed:12939418 ]
- Gupta D, Sabesan S, Brewer CF: Selective inhibition of N-acetylglucosamine and galactose-specific lectins including the 14-kDa vertebrate lectin by novel synthetic biantennary oligosaccharides. Eur J Biochem. 1993 Sep 15;216(3):789-97. [PubMed:8404897 ]
- Sutherlin ME, Nishimori I, Caffrey T, Bennett EP, Hassan H, Mandel U, Mack D, Iwamura T, Clausen H, Hollingsworth MA: Expression of three UDP-N-acetyl-alpha-D-galactosamine:polypeptide GalNAc N-acetylgalactosaminyltransferases in adenocarcinoma cell lines. Cancer Res. 1997 Nov 1;57(21):4744-8. [PubMed:9354435 ]
- Kariniemi AL, Virtanen I: Dolichos biflorus agglutinin (DBA) reveals a similar basal cell differentiation in normal and psoriatic epidermis. Histochemistry. 1989;93(2):129-32. [PubMed:2482277 ]
- Yuki N: Infectious origins of, and molecular mimicry in, Guillain-Barre and Fisher syndromes. Lancet Infect Dis. 2001 Aug;1(1):29-37. [PubMed:11871407 ]
- Tao X, Gao G, Zhang HZ, Zhu DX, Boersma A, Lamblin G, Han KK: Isolation and characterization of human urinary colony-stimulating factor. Biol Chem Hoppe Seyler. 1987 Mar;368(3):187-94. [PubMed:3496105 ]
- Hiruma T, Togayachi A, Okamura K, Sato T, Kikuchi N, Kwon YD, Nakamura A, Fujimura K, Gotoh M, Tachibana K, Ishizuka Y, Noce T, Nakanishi H, Narimatsu H: A novel human beta1,3-N-acetylgalactosaminyltransferase that synthesizes a unique carbohydrate structure, GalNAcbeta1-3GlcNAc. J Biol Chem. 2004 Apr 2;279(14):14087-95. Epub 2004 Jan 14. [PubMed:14724282 ]
- Chikakiyo H, Kunishige M, Yoshino H, Asano A, Sumitomo Y, Endo I, Matsumoto T, Mitsui T: Delayed motor and sensory neuropathy in a patient with brainstem encephalitis. J Neurol Sci. 2005 Jul 15;234(1-2):105-8. [PubMed:15936038 ]
- Roelen HC, Bijsterbosch MK, Bakkeren HF, van Berkel TJ, Kempen HJ, Buytenhek M, van der Marel GA, van Boom JH: Water-soluble cholesteryl-containing phosphorothioate monogalactosides: synthesis, properties, and use in lowering blood cholesterol by directing plasma lipoproteins to the liver. J Med Chem. 1991 Mar;34(3):1036-42. [PubMed:2002447 ]
- Smith PL, Bousfield GR, Kumar S, Fiete D, Baenziger JU: Equine lutropin and chorionic gonadotropin bear oligosaccharides terminating with SO4-4-GalNAc and Sia alpha 2,3Gal, respectively. J Biol Chem. 1993 Jan 15;268(2):795-802. [PubMed:8419356 ]
- Szkudlinski MW, Thotakura NR, Tropea JE, Grossmann M, Weintraub BD: Asparagine-linked oligosaccharide structures determine clearance and organ distribution of pituitary and recombinant thyrotropin. Endocrinology. 1995 Aug;136(8):3325-30. [PubMed:7628367 ]
- Taguchi K, Ren J, Utsunomiya I, Aoyagi H, Fujita N, Ariga T, Miyatake T, Yoshino H: Neurophysiological and immunohistochemical studies on Guillain-Barre syndrome with IgG anti-GalNAc-GD1a antibodies-effects on neuromuscular transmission. J Neurol Sci. 2004 Oct 15;225(1-2):91-8. [PubMed:15465091 ]
- Hoyte K, Kang C, Martin PT: Definition of pre- and postsynaptic forms of the CT carbohydrate antigen at the neuromuscular junction: ubiquitous expression of the CT antigens and the CT GalNAc transferase in mouse tissues. Brain Res Mol Brain Res. 2002 Dec 30;109(1-2):146-60. [PubMed:12531524 ]
- Brunngraber EG, Brown BD, Aro A: Distribution and age-dependent concentration in brain tissue of glycoproteins containing N-acetylgalactosamine. Neurobiology. 1975 Dec;5(6):339-46. [PubMed:1207868 ]
- Maury CP: Carbohydrate patterns of endoscopic mucosal biopsies in cancer of the stomach and chronic gastritis. Clin Chim Acta. 1982 Dec 9;126(2):155-9. [PubMed:7151277 ]
- Elshenawy S, Pinney SE, Stuart T, Doulias PT, Zura G, Parry S, Elovitz MA, Bennett MJ, Bansal A, Strauss JF 3rd, Ischiropoulos H, Simmons RA: The Metabolomic Signature of the Placenta in Spontaneous Preterm Birth. Int J Mol Sci. 2020 Feb 4;21(3). pii: ijms21031043. doi: 10.3390/ijms21031043. [PubMed:32033212 ]
- (). Pastuszak I, Drake R, Elbein AD. Kidney N-acetylgalactosamine (GalNAc)-1-phosphate kinase, a new pathway of GalNAc activation. J Biol Chem. 1996 Aug 23;271(34):20776-82.. .
|
---|